DarioHealth Corp (DRIO)

Etorro trading 970x250

About DarioHealth Corp

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Tools, which are devices that integrate with applications on a user’s smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine. It also sells device-specific disposables test strip cartridges, lancets, and Dario Blood Glucose Monitoring System; and Dario Smart Diabetes Management Solution, which includes tools to help diabetic patients manage their disease. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was founded in 2011 and is based in New York, New York. Address: 142 West 57th Street, New York, NY, United States, 10019

DarioHealth Corp News and around…

Latest news about DarioHealth Corp (DRIO) common stock and company :

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Unveils Innovative Digital Musculoskeletal Solution
18 Oct, 2021 FinancialContent
DarioHealth Unveils its Digital Musculoskeletal Solution Dario Move at HLTH 2021
18 Oct, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of Dario Move, a new digital physical therapy solution to manage common musculoskeletal (MSK) conditions that drive significant costs for employers and health plans. The solution is being unveiled at HLTH 2021, one of the largest and most important conferences for health innovation, which is taking place in a hybrid format (in-person and virtual) from October 17-20 in Boston.

44 Biggest Movers From Yesterday
15 Oct, 2021 FinancialContent

Gainers Benessere Capital Acquisition Corp. (NASDAQ: BENER) shares jumped 66.5% to close at $0.4530 on Thursday. Grove, Inc. ...

12 Health Care Stocks Moving In Thursday's Intraday Session
14 Oct, 2021 FinancialContent

Gainers NRX Pharmaceuticals (NASDAQ:NRXP) shares increased by 37.92% to $13.02 during Thursday's regular session. As of 12:30 EST, ...

DarioHealth Corp. Enters Landmark Agreement with Leading National Health Plan
14 Oct, 2021 FinancialContent

DarioHealth (NASDAQ: DRIO), a leader in the global digital-therapeutics (“DTx”) market, today announced its entry into an ...

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters Landmark Agreement with Leading National Health Plan
14 Oct, 2021 FinancialContent
DarioHealth Announces Agreement with Leading National Health Plan
14 Oct, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today it has entered into an agreement with one of the largest U.S. national health plans ("Plan") to offer its self-insured employer customers the Dario digital behavioral health solution as part of its behavioral health offering. Initial members are expected on the platform in the fourth fiscal quarter of 2021, with additional rollout anticipated over the course of 2022. Dario will be paid a m

DarioHealth Corp. Enters Agreement with Global Employer for Metabolic and Musculoskeletal Health Solutions
07 Oct, 2021 Yahoo! Finance

DarioHealth (NASDAQ: DRIO), a leader in the global digital-therapeutics (“DTx”) market, today announced an agreement with a global company based in the United States to provide its integrated digital health management solution for diabetes, hypertension, and musculoskeletal (“MSK”) health. According to the update, the contract is expected to launch in the first quarter of 2022. “We are pleased to add another self-insured employer as a customer bringing our total additions in the second quarter t

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Enters Agreement with Global Employer for Metabolic and Musculoskeletal Health Solutions
07 Oct, 2021 FinancialContent
DarioHealth Announces Agreement with Global Employer for Metabolic and Musculoskeletal Health Solutions
07 Oct, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today an agreement with a global company based in the United States ("Company") to provide its integrated digital health management solution for diabetes, hypertension, and musculoskeletal (MSK) health. The contract is expected to launch in the first quarter of 2022.

Looking Into DarioHealth's Return On Capital Employed
04 Oct, 2021 FinancialContent

DarioHealth (NASDAQ:DRIO) brought in sales totaling $5.26 million during Q2 according to data provided by Benzinga Pro. However, ...

DarioHealth to Participate in the Cantor Fitzgerald Virtual Global Healthcare Conference
24 Sep, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in a fireside chat during the Cantor Fitzgerald Virtual Global Healthcare Conference, which is being held September 27-30, 2021.

Desperate for Solutions, Diabetes and Obesity Healthcare Sectors Find Answers, Hope in Innovative Tech
23 Sep, 2021 FinancialContent
InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Exec Featured Speaker at American Health Insurance Plans National Conference
17 Sep, 2021 FinancialContent
DarioHealth Chief Medical Officer Dr. Omar Manejwala to Speak at American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles
17 Sep, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company's Chief Medical Officer, Dr. Omar Manejwala, will present at the annual American Health Insurance Plans National Conference on Medicare, Medicaid and Dual Eligibles being held virtually on September 22nd, 2021 at 12:45 p.m. EST.

DarioHealth Chosen by Northeast Regional Employer
09 Sep, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its suite of digital therapeutics for diabetes, hypertension and pre-diabetes to a Northeast regional employer ("Employer"). The contract is expected to contribute revenue beginning in the first quarter of 2022.

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Signs Behavioral Health Services Contract, Continues Growth in Employer Market
08 Sep, 2021 FinancialContent
DarioHealth Selected by Another Employer for Behavioral Health Services
08 Sep, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has entered into an agreement to provide its digital behavioral health platform to a casino resort company ("Casino Resort Company") in California. The contract is expected to contribute revenue beginning in the fourth quarter of 2021.

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Partners With Regional Primary Care Provider PeopleOne Health To Provide Digital Health Solutions
31 Aug, 2021 FinancialContent

DarioHealth (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, has finalized a contract with PeopleOne Health to be ...

DarioHealth Chosen by Regional Primary Care Provider PeopleOne Health as its Digital Behavioral Health Partner
31 Aug, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today that it has been selected by regional primary care provider PeopleOne Health to be the digital behavioral health solution of choice for patients beginning this September. This contract represents Dario's continuing growth in the provider market, leveraging its expanded product portfolio.

DRIO: Dario’s RPM Accelerating
18 Aug, 2021 Yahoo! Finance

By John Vandermosten, CFA NASDAQ:DRIO READ THE FULL DRIO RESEARCH REPORT Second Quarter 2021 Financial and Operational Results On August 16, 2021, DarioHealth Corp. (NASDAQ:DRIO) announced its second quarter 2021 operational and financial results and filed its Form 10-Q . Dario hosted a conference call the same morning to discuss results in further detail. Highlights for the second quarter ended

Why Is DarioHealth Falling After Earnings?
16 Aug, 2021 FinancialContent

DarioHealth Corp(NASDAQ: DRIO)reported second-quarterFY21 revenue growth of 194% year-on-year to $5.26 million, ...

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Releases Q2 2021 Results, Operational Highlights
16 Aug, 2021 FinancialContent
Recap: DarioHealth Q2 Earnings
16 Aug, 2021 FinancialContent

Shares of DarioHealth (NASDAQ:DRIO) fell 0.5% in pre-market trading after the company reported Q2 results. Quarterly ...

DarioHealth Reports Strong Second Quarter 2021 Results and Operational Highlights
16 Aug, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the second quarter of 2021 and provided a corporate and commercial update.

Earnings Scheduled For August 16, 2021
16 Aug, 2021 FinancialContent

Companies Reporting Before The Bell • Entera Bio (NASDAQ:ENTX) is likely to report earnings for its second ...

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Study Results at Annual Conference of Diabetes Care and Education Specialists
12 Aug, 2021 FinancialContent
DarioHealth Presents New Study Demonstrating Significant Clinical Impact of Personalized Digital Interventions Based on Real-Time Data
12 Aug, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced a new study at the American Association of Diabetes Care and Education Specialists (ADCES) annual conference demonstrating the impact of Dario's intelligent personalization platform.

InvestorNewsBreaks – DarioHealth Corp. (NASDAQ: DRIO) Announces Plans to Release Q2 Results
09 Aug, 2021 FinancialContent
DarioHealth to Report Second Quarter 2021 Results on Monday, August 16
09 Aug, 2021 Yahoo! Finance

DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the second quarter ended June 30, 2021 on Monday, August 16, 2021, and host a conference call and webcast at 8:30 am Eastern Time.

DarioHealth Corp (DRIO) is a NASDAQ Common Stock listed in , ,

970x250